Loading clinical trials...
Loading clinical trials...
To give chest compressions during cardiopulmonary resuscitation (CPR), mechanical chest compression devices can be used. During synchronous 30:2 CPR, the standard setting on these devices leave an automated 3-second chest compression pause after 30 compressions to facilitate caregivers in providing two ventilations. With this standard setting, research has shown that in less than half of ventilation pauses during CPR, those two ventilations are given. Increasing the ventilation pause duration to 5 seconds instead of 3 seconds is also an option following current guideline recommendations, and aligns with measured ventilation pause duration in manual CPR. Increasing pause duration to 5 seconds could result in an increased ventilation success rate. This multicenter randomized controlled trial will randomize LUCAS® mechanical compression devices to a standard setting of 3- or 5-second compression pauses. The main outcome will be the percentage of ventilation pauses in which two ventilations are successfully given. Secondary outcomes include the restoration of spontaneous circulation (ROSC), and the difference in (neurologically intact) survival. No study has been performed to evaluate this effect yet.
Age
16 - No limit years
Sex
ALL
Healthy Volunteers
No
Ambulance Amsterdam
Amsterdam, North Holland, Netherlands
Regionale Ambulance Voorziening Kennemerland - Ambulancezorg GGD Kennemerland
Haarlem, North Holland, Netherlands
Start Date
March 1, 2025
Primary Completion Date
September 1, 2026
Completion Date
April 1, 2027
Last Updated
February 13, 2025
692
ESTIMATED participants
5-second ventilation pause duration during mechanical CPR
OTHER
3-second ventilation pause duration during mechanical CPR
OTHER
Lead Sponsor
Amsterdam UMC, location VUmc
NCT07438938
NCT07363772
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions